Skip to main content

3 Result(s)

within Zorawar S. Noor Remove this filter

and

  1. Article

    Open Access

    Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis

    Cell-free DNA (cfDNA) is attractive for many applications, including detecting cancer, identifying the tissue of origin, and monitoring. A fundamental task underlying these applications is SNV calling from cfD...

    Shuo Li, Zorawar S. Noor, Weihua Zeng, Mary L. Stackpole… in Nature Communications (2021)

    Download PDF (938 KB) View Article

  2. No Access

    Chapter

    EGFR Targeted Therapy

    The identification of sensitizing mutations in the epidermal growth factor receptor (EGFR) gene in patients with non-small cell lung cancer (NSCLC) and the development of EGFR-tyrosine kinase inhibitors (EGFR TKI...

    Zorawar S. Noor, Jonathan W. Goldman in Targeted Therapies for Lung Cancer (2019)

  3. No Access

    Article

    Updates on Targeted Therapy for Triple-Negative Breast Cancer (TNBC)

    We will provide a brief update of the most recent advances in targeted therapies for triple-negative breast cancer (TNBC) to help guide the practicing oncologist faced with the dilemma of how to treat this com...

    Zorawar S. Noor, Aashini Master in Current Breast Cancer Reports (2018)